BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31254308)

  • 1. Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease.
    Larouche-Lebel É; Loughran KA; Oyama MA; Solter PF; Laughlin DS; Sánchez MD; Assenmacher CA; Fox PR; Fries RC
    J Vet Intern Med; 2019 Jul; 33(4):1571-1584. PubMed ID: 31254308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease.
    Larouche-Lebel É; Loughran KA; Huh T; Oyama MA
    J Vet Intern Med; 2021 Jan; 35(1):22-32. PubMed ID: 33368659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of angiotensin receptor blockers and angiotensin-converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease.
    Huh T; Larouche-Lebel É; Loughran KA; Oyama MA
    J Vet Intern Med; 2021 Jan; 35(1):33-42. PubMed ID: 33135833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease.
    Hammond HH; Ames MK; Domenig O; Scansen BA; Yang NT; Wilson MD; Sunshine E; Brunk K; Masters A
    J Vet Intern Med; 2023; 37(3):875-886. PubMed ID: 36951394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure.
    Basu R; Poglitsch M; Yogasundaram H; Thomas J; Rowe BH; Oudit GY
    J Am Coll Cardiol; 2017 Feb; 69(7):805-819. PubMed ID: 28209222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcifediol supplementation on renin-angiotensin-aldosterone system mediators in dogs with chronic kidney disease.
    Miller M; Quimby J; Langston C; Ames M; Parker VJ
    J Vet Intern Med; 2022 Sep; 36(5):1693-1699. PubMed ID: 35962709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure.
    Chirinos JA; Cohen JB; Zhao L; Hanff T; Sweitzer N; Fang J; Corrales-Medina V; Anmar R; Morley M; Zamani P; Bhattacharya P; Brandimarto J; Jia Y; Basso MD; Wang Z; Ebert C; Ramirez-Valle F; Schafer PH; Seiffert D; Gordon DA; Cappola T
    Hypertension; 2020 Nov; 76(5):1526-1536. PubMed ID: 32981365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. A novel aspect of endothelium dysfunction.
    Huang H; Arnal JF; Llorens-Cortes C; Challah M; Alhenc-Gelas F; Corvol P; Michel JB
    Circ Res; 1994 Sep; 75(3):454-61. PubMed ID: 8062419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.
    Donoghue M; Hsieh F; Baronas E; Godbout K; Gosselin M; Stagliano N; Donovan M; Woolf B; Robison K; Jeyaseelan R; Breitbart RE; Acton S
    Circ Res; 2000 Sep; 87(5):E1-9. PubMed ID: 10969042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
    Hamming I; van Goor H; Turner AJ; Rushworth CA; Michaud AA; Corvol P; Navis G
    Exp Physiol; 2008 May; 93(5):631-8. PubMed ID: 18192334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure.
    Wang J; Li N; Gao F; Song R; Zhu S; Geng Z
    J Renin Angiotensin Aldosterone Syst; 2015 Sep; 16(3):553-8. PubMed ID: 25869724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure.
    Úri K; Fagyas M; Mányiné Siket I; Kertész A; Csanádi Z; Sándorfi G; Clemens M; Fedor R; Papp Z; Édes I; Tóth A; Lizanecz E
    PLoS One; 2014; 9(4):e87845. PubMed ID: 24691269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the tissue reninangiotensin-aldosterone system in dogs with chronic mild regurgitation through the mitral valve.
    Fujii Y; Orito K; Muto M; Wakao Y
    Am J Vet Res; 2007 Oct; 68(10):1045-50. PubMed ID: 17916008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease.
    Adin D; Kurtz K; Atkins C; Papich MG; Vaden S
    J Vet Intern Med; 2020 Jan; 34(1):53-64. PubMed ID: 31769114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Renin-Angiotensin-Aldosterone System in Greyhounds and Non-Greyhound Dogs.
    Martinez J; Kellogg C; Iazbik MC; Couto CG; Pressler BM; Hoepf TM; Radin MJ
    J Vet Intern Med; 2017 Jul; 31(4):988-993. PubMed ID: 28488321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationship between renin-angiotensin-aldosterone system and oxidative stress in chronic heart failure patients with or without renal impairment.
    Reina-Couto M; Afonso J; Carvalho J; Morgado L; Ronchi FA; de Oliveira Leite AP; Dias CC; Casarini DE; Bettencourt P; Albino-Teixeira A; Morato M; Sousa T
    Biomed Pharmacother; 2021 Jan; 133():110938. PubMed ID: 33171402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.